Source:Journal of Allergy and Clinical Immunology
Author(s): Jop Jans, Matthew Pettengill, Dhohyung Kim, Cas van der Made, Ronald de Groot, Stefanie Henriet, Marien I. de Jonge, Gerben Ferwerda, Ofer Levy
Teaser
This study provides evidence of a first line of human humoral defense against RSV infection in early life including the presence of natural neutralizing anti-RSV IgM as well as an IFN-β-mediated newborn B cell activation.http://ift.tt/2gaU5aH
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου